Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$903M |
| 2 |
Apple
AAPL
|
+$843M |
| 3 |
Warner Bros
WBD
|
+$615M |
| 4 |
Home Depot
HD
|
+$580M |
| 5 |
Amazon
AMZN
|
+$403M |
Top Sells
| 1 |
AT&T
T
|
+$770M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 4 |
Marathon Petroleum
MPC
|
+$158M |
| 5 |
S&P Global
SPGI
|
+$154M |
Sector Composition
| 1 | Technology | 23.96% |
| 2 | Healthcare | 14.75% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Woori Financial
WF
$13.8B
| $333K | ﹤0.01% |
11,795
-3,888
| -25% | -$110K |
|
3977
Cocrystal Pharma
COCP
$15.1M
| $331K | ﹤0.01% |
67,450
+733
| +1% | +$3.6K |
|
|
HOFV
3978
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $331K | ﹤0.01% |
25,420
-16,743
| -40% | -$218K |
|
3979
Regis Corp
RGS
$66.7M
| $331K | ﹤0.01% |
15,335
-15,383
| -50% | -$332K |
|
3980
Oxbridge Re Holdings
OXBR
$17.7M
| $330K | ﹤0.01% |
98,851
+4,273
| +5% | +$14.3K |
|
3981
CASI Pharmaceuticals
CASI
$36.9M
| $329K | ﹤0.01% |
115,194
+1,088
| +1% | +$3.11K |
|
3982
Milestone Scientific
MLSS
$46.4M
| $329K | ﹤0.01% |
359,905
+6,658
| +2% | +$6.09K |
|
3983
Research Frontiers
REFR
$43.7M
| $329K | ﹤0.01% |
189,585
+1,716
| +0.9% | +$2.98K |
|
3984
Presidio Property Trust
SQFT
$7.31M
| $329K | ﹤0.01% |
10,345
+8,327
| +413% | +$265K |
|
3985
Lantern Pharma
LTRN
$42.9M
| $328K | ﹤0.01% |
57,564
+521
| +0.9% | +$2.97K |
|
3986
KLX Energy Services
KLXE
$33.9M
| $327K | ﹤0.01% |
75,600
+5,281
| +8% | +$22.8K |
|
3987
Live Ventures
LIVE
$54.1M
| $327K | ﹤0.01% |
13,102
-26
| -0.2% | -$649 |
|
|
CORR
3988
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $326K | ﹤0.01% |
129,375
-7,380
| -5% | -$18.6K |
|
3989
Equillium
EQ
$112M
| $324K | ﹤0.01% |
159,150
+1,928
| +1% | +$3.93K |
|
3990
Werewolf Therapeutics
HOWL
$64.5M
| $324K | ﹤0.01% |
79,280
-209,025
| -73% | -$854K |
|
3991
Neuropace
NPCE
$321M
| $324K | ﹤0.01% |
65,570
-51,298
| -44% | -$253K |
|
3992
Quince Therapeutics
QNCX
$87M
| $324K | ﹤0.01% |
146,214
-136,897
| -48% | -$303K |
|
|
IIII
3993
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $324K | ﹤0.01% |
32,969
+17,020
| +107% | +$167K |
|
3994
SELLAS Life Sciences
SLS
$195M
| $322K | ﹤0.01% |
144,719
+7,823
| +6% | +$17.4K |
|
3995
electroCore
ECOR
$37.2M
| $321K | ﹤0.01% |
42,064
+930
| +2% | +$7.1K |
|
|
LEV
3996
DELISTED
The Lion Electric Company
LEV
| $321K | ﹤0.01% |
76,445
+22,189
| +41% | +$93.2K |
|
3997
Banzai International
BNZI
$10.2M
| $320K | ﹤0.01% |
65
+24
| +59% | +$118K |
|
|
AMRN
3998
Amarin Corp
AMRN
$309M
| $319K | ﹤0.01% |
10,719
| – | – |
|
|
AXDX
3999
DELISTED
Accelerate Diagnostics
AXDX
| $318K | ﹤0.01% |
32,099
-26,414
| -45% | -$262K |
|
|
OMGA
4000
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $318K | ﹤0.01% |
83,826
-189,070
| -69% | -$717K |
|